DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue 02 · Volume 54 · March 2021 DOI: 10.1055/s-011-50504

Review

  • 53
    Gründer, Gerhard; Bauknecht, Philipp; Klingberg, Stefan; Leopold, Karolina; Paulzen, Michael; Schell, Stefanie; Stengler, Katarina; Leucht, Stefan:

    Treatment Goals for Patients with Schizophrenia — A Narrative Review of Physician and Patient Perspectives

    Supporting Information (PDF)

    • Original Paper

  • 60
    Sakurai, Hitoshi; Yasui-Furukori, Norio; Suzuki, Takefumi; Uchida, Hiroyuki; Baba, Hajime; Watanabe, Koichiro; Inada, Ken; Kikuchi, Yuka Sugawara; Kikuchi, Toshiaki; Katsuki, Asuka; Kishida, Ikuko; Kato, Masaki:

    Pharmacological Treatment of Schizophrenia: Japanese Expert Consensus

    Open Access
    Supplementary Material (PDF)
  • 68
    Shi, Hui; Guan, Xiao Ni; Liu, Dian Ying; Zhu, Lin; Wu, Zhi Wei; Luo, Guo Zhi; Wang, Jun; Xiu, Mei Hong; Zhang, Xiang Yang:

    Sex-specific Association of Antipsychotic-induced Weight Gain and Treatment Response for Antipsychotic-Naive First Episode Schizophrenia Patients: A Prospective 8-week Longitudinal Study

  • 75
    Bauer, Michael; Glenn, Tasha; Alda, Martin; Grof, Paul; Monteith, Scott; Rasgon, Natalie; Severus, Emanuel; Whybrow, Peter C.:

    Association between Adherence with an Atypical Antipsychotic and with Other Psychiatric Drugs in Patients with Bipolar Disorder

  • 81
    Hahn, Martina; Müller, Daniel J.; Roll, Sibylle C.:

    Frequencies of Genetic Polymorphisms of Clinically Relevant Gene-Drug Pairs in a German Psychiatric Inpatient Population

  • 91
    Kaufman, Daniel E.; Nihal, Asawer M.; Leppo, Janan D.; Staples, Kelly M.; McCall, Kenneth L.; Piper, Brian J.:

    Opioid Mortality Following Implementation of Medical Cannabis Programs in the United States

    Supplementary Material (PDF)